SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-20-016465
Filing Date
2020-07-21
Accepted
2020-07-21 16:45:55
Documents
2
Group Members
GEORGE R. ROBERTSHENRY R. KRAVISKKR & CO. INC.KKR GROUP HOLDINGS CORP.KKR GROUP PARTNERSHIP L.P.KKR MANAGEMENT LLPKKR PHORM INVESTORS GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A brhc10013650_sc13da.htm SC 13D/A 269916
2 EXHIBIT G brhc10013650_99-g.htm EX-99.G 35781
  Complete submission text file 0001140361-20-016465.txt   307605
Mailing Address 75 CASTILIAN DRIVE GOLETA CA 93117
Business Address 75 CASTILIAN DRIVE GOLETA CA 93117 805-456-1300
Transphorm, Inc. (Subject) CIK: 0001715768 (see all company filings)

IRS No.: 821858829 | State of Incorp.: DE | Fiscal Year End: 0603
Type: SC 13D/A | Act: 34 | File No.: 005-90877 | Film No.: 201039282
SIC: 3674 Semiconductors & Related Devices

Mailing Address C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019
Business Address C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019 212-230-9742
KKR Phorm Investors L.P. (Filed by) CIK: 0001806548 (see all company filings)

IRS No.: 473998300 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A